GTS Securities’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-36,700
Closed -$103K 1782
2024
Q3
$103K Sell
36,700
-20,700
-36% -$47.4K ﹤0.01% 3796
2024
Q2
$70.6K Buy
57,400
+8,400
+17% +$7.54K ﹤0.01% 3676
2024
Q1
$38.9K Buy
49,000
+17,900
+58% +$16.3K ﹤0.01% 3655
2023
Q4
$29.6K Sell
31,100
-3,900
-11% -$3.83K ﹤0.01% 3882
2023
Q3
$37.8K Buy
+35,000
New +$41.6K ﹤0.01% 3744

Other funds holding CLOV

GTS Securities's CLOV Position: Q1 2026 in Review

GTS Securities sold out of Clover Health Investments (CLOV) in Q1 2026, closing a stake of 11,123 shares — an estimated $26.1K sold.

GTS Securities first reported a position in CLOV in Q1 2024 and held it in 3 quarters. The position peaked at $89.8K in Q2 2024. 208 funds tracked by Wall St. Rank hold CLOV as of Q1 2026.

  • GTS Securities reported no remaining Clover Health Investments position as of Q1 2026 after selling out during the quarter.
  • GTS Securities sold 11,123 Clover Health Investments shares in Q1 2026, an estimated $26.1K.
  • GTS Securities first reported a position in Clover Health Investments in Q1 2024 and held it in 3 quarters.
  • GTS Securities's Clover Health Investments position peaked at $89.8K in Q2 2024.
  • 208 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.